These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 9374086)
1. Doxorubicin plus paclitaxel in advanced breast cancer. Dombernowsky P; Boesgaard M; Andersen E; Jensen BV Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-15-S17-8. PubMed ID: 9374086 [TBL] [Abstract][Full Text] [Related]
2. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer. Dombernowsky P; Gehl J; Boesgaard M; Paaske T; Jensen BV Semin Oncol; 1996 Oct; 23(5 Suppl 11):23-7. PubMed ID: 8893895 [TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894 [TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic breast cancer with paclitaxel and doxorubicin. Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BW; Ejlertsen B Semin Oncol; 1995 Dec; 22(6 Suppl 15):13-7. PubMed ID: 8643964 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel plus doxorubicin in metastatic breast cancer: preliminary analysis of cardiotoxicity. Martin M; Lluch A; Ojeda B; Barnabas A; Colomer R; Massuti B; Benito D Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-26-S17-30. PubMed ID: 9374088 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer. Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BV Semin Oncol; 1996 Feb; 23(1 Suppl 1):13-8. PubMed ID: 8629030 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer. Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090 [TBL] [Abstract][Full Text] [Related]
8. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety. Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032 [TBL] [Abstract][Full Text] [Related]
9. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience. Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333 [TBL] [Abstract][Full Text] [Related]
10. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer. Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896 [TBL] [Abstract][Full Text] [Related]
11. The sequential administration of combined doxorubicin and paclitaxel in the treatment of advanced breast cancer. Frassineti GL; Zoli W; Tienghi A; Ravaioli A; Milandri C; Gentile A; Salzano E; Amadori D Semin Oncol; 1996 Oct; 23(5 Suppl 12):22-8. PubMed ID: 8941407 [TBL] [Abstract][Full Text] [Related]
12. A Phase I/II study of paclitaxel and doxorubicin in the treatment of advanced breast cancer. Amadori D; Frassineti GL; Zoli W; Tienghi A; Ravaioli A; Casadei Giunchi D; Gentile A; Salzano E Semin Oncol; 1996 Feb; 23(1 Suppl 1):19-23. PubMed ID: 8629031 [TBL] [Abstract][Full Text] [Related]
13. Activity and safety of epirubicin plus paclitaxel in advanced breast cancer. Conte PF; Michelotti A; Baldini E; Tibaldi C; DaPrato M; Salvadori B; Giannessi PG; Gentile A; Biadi O; Mariani M Semin Oncol; 1996 Feb; 23(1 Suppl 1):28-32. PubMed ID: 8629033 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer. Greco FA; Hainsworth JD Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096 [TBL] [Abstract][Full Text] [Related]
15. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma. Holmes FA Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702 [TBL] [Abstract][Full Text] [Related]
16. Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer. Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-77-S17-80. PubMed ID: 9374100 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer. Conte PF; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi PG; Gentile A Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience. Sledge GW; Robert N; Sparano JA; Cobeligh M; Goldstein LJ; Neuberg D; Rowinsky E; Baughman C; McCaskill-Stevens W Semin Oncol; 1994 Oct; 21(5 Suppl 8):15-8. PubMed ID: 7939756 [TBL] [Abstract][Full Text] [Related]
19. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer. Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel plus doxorubicin in breast cancer: an Italian experience. Frassineti GL; Zoli W; Silvestro L; Serra P; Milandri C; Tienghi A; Gianni L; Gentile A; Salzano E; Amadori D Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-19-S17-25. PubMed ID: 9374087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]